Eur Rev Med Pharmacol Sci 2024; 28 (8): 3112-3119
DOI: 10.26355/eurrev_202404_36027

Fisetin ameliorates methotrexate induced liver fibrosis

A. Kayalı, E.S. Bora, H. Acar, G. Yılmaz, O. Erbaş

Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Türkiye. ahmet.kayali@ikc.edu.tr


OBJECTIVE: Methotrexate (MTX), a widely used chemotherapeutic and immunosuppressive agent, is associated with hepatotoxicity, leading to liver fibrosis and cirrhosis. This study explores the regenerative and reparative effects of fisetin, a flavonoid with known antioxidant and anti-inflammatory properties, on MTX-induced liver fibrosis in a rat model.

MATERIALS AND METHODS: Thirty-six male Wistar albino rats were divided into normal, MTX and saline, and MTX and fisetin. Liver injury was induced in the latter two groups using a single intraperitoneal dose of MTX (20 mg/kg). Fisetin (50 mg/kg/day) or saline was administered intraperitoneally for ten days. After sacrifice, liver tissues were subjected to histopathological evaluation and biochemical analyses, including Transforming Growth Factor-β1 (TGF-beta), sirtuins-1 (SIRT-1), malondialdehyde (MDA), cytokeratin 18, thrombospondin 1, and alanine transaminase (ALT) levels.

RESULTS: MTX administration significantly increased liver injury markers, including TGF-beta, MDA, cytokeratin 18, thrombospondin 1, and ALT, while reducing SIRT-1 levels. Fisetin treatment attenuated these effects, demonstrating its potential therapeutic impact. Histopathological analysis confirmed that fisetin mitigated MTX-induced hepatocyte necrosis, fibrosis, and cellular infiltration.

CONCLUSIONS: This study proves that fisetin administration can alleviate MTX-induced liver damage in rats. The reduction in oxidative stress, inflammation, and apoptosis, along with the histological improvements, suggests fisetin’s potential as a therapeutic agent against MTX-induced hepatotoxicity. Further investigations and clinical studies are warranted to validate these findings and assess fisetin’s translational potential in human cases of MTX-induced liver damage.

Free PDF Download

To cite this article

A. Kayalı, E.S. Bora, H. Acar, G. Yılmaz, O. Erbaş
Fisetin ameliorates methotrexate induced liver fibrosis

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 8
Pages: 3112-3119
DOI: 10.26355/eurrev_202404_36027